Skip to main content
UCSF Medical Center
UCSF Benioff Children’s Hospitals:   San Francisco | Oakland
UCSF Logo
  • UCSF Logo
  • Home
  • Find a Doctor
      • Find a Doctor

      • Meet Our Doctors

      • Second Opinion

  • Medical Services
      • Clinics & Programs

      • Request an Appointment

      • Clinical Trials

  • CME
      • Continuing Medical Education

  • Refer a Patient
      • Refer a Patient

      • Refer a Pediatrics Patient

      • Transfer a Patient

      • Request a Consultation

      • UCSF MD Link

UCSF MedConnection

Resources from leading medical experts from UCSF Medical Center & UCSF Benioff Children’s Hospitals

Search by:

  • SPECIALTY
      • CANCER

      • DERMATOLOGY

      • ENDOCRINE SURGERY

      • FETAL TREATMENT

      • CARDIOLOGY & HEART SURGERY

      • NEUROLOGY

      • NEUROSURGERY

      • STROKE CENTER

      • OPHTHALMOLOGY

      • ORTHOPEDICS

      • OTOLARYNGOLOGY

      • PEDIATRICS

      • PEDIATRIC BRAIN CENTER

      • PEDIATRIC HEART CENTER

      • PULMONOLOGY

      • SPINE

      • UROLOGY

      • WOMEN'S HEALTH

Ajay Maker, MD, FACS

Surgical oncologist, Chief, Division of Surgical Oncology

Ajay Maker, MD, FACS

Dr. Ajay V. Maker is a surgical oncologist and chief of the UCSF Division of Surgical Oncology. He is an expert in surgically treating complex gastrointestinal and hepatopancreatobiliary diseases (those affecting the liver, pancreas, gallbladder and bile ducts), as well as melanomas and sarcomas.

Maker's research aims to improve early detection of pancreas cancer and to develop new therapies for treating metastases (cancers that have spread from a primary site in the body). Under grants awarded by the Department of Defense and National Institutes of Health (NIH), he works on designing novel immunotherapies (treatments that harness the immune system to fight tumors), particularly for liver metastases from colon cancer.

Maker earned his medical degree at Yale School of Medicine. He completed a residency in general surgery at Brigham and Women's Hospital, an affiliate of Harvard Medical School. He trained in surgical oncology at the NIH and completed postdoctoral studies in tumor immunology at the National Cancer Institute; this research included working in trials that led to approval by the Food and Drug Administration of ipilimumab as a new treatment for metastatic melanoma. He later completed a fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center and then gained experience in minimally invasive surgical techniques at the University of Paris. He came to UCSF from his hometown of Chicago, where he was a tenured professor of surgery and of microbiology and immunology at the University of Illinois at Chicago.

In 2015, Maker was the European Society of Surgical Oncology's international traveling fellow and was later honored with the Society of Surgical Oncology's Clinical Investigator Award. He has published more than 170 manuscripts, abstracts and book chapters, and he lectures all over the world. He serves on the editorial boards of many surgical and scientific journals; serves on NIH study sections, which evaluate the merit of proposed research; and has held leadership positions in numerous academic and scientific societies, including program chair of the Americas Hepato-Pancreato-Biliary Association and chair of the Society of Surgical Oncology's gastrointestinal working group. He is also active in various medical societies, including the Surgical Biology Club, Western Surgical Association, American Society of Clinical Oncology and Pancreas Club. He has been named numerous times to Castle Connolly's Top Doctors and Top Doctors for Cancer lists. He is a fellow of the American College of Surgeons and Society of Surgical Oncology.

View Full Profile

View Profile


Related Videos

How Technology, Human Values and New Scrutiny of Old Methods Are Improving Cancer Outcomes Video

How Technology, Human Values and New Scrutiny of Old Methods Are Improving Cancer Outcomes

Three surgical oncologists offer exciting news on hepatobiliary, thyroid and breast cancers. First up is a look at benefits of minimally invasive robotic surgery for rectal cancers; regional therapy for metastatic GI cancer; 3D virtual ...

Additional Links

  • Refer a Patient

  • Find a Doctor

  • Medical Services

  • Clinical Trials

  • Continuing Medical Education

This Video Content is available for informational and educational purposes only. UCSF does not make any representation or warranties with respect to the accuracy, applicability, fitness, or completeness of the Video Content. The Regents of the University of California and its officers, agents or employees (UCSF) will not be liable for any damages of any kind arising from any use of the Video Content, which is provided as is, and without warranties. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.

©2002 - 2021 The Regents of The University of California